Recommended videos you might also like
16:21
Refractory Hypertension: What is Essential to Know in 2017 - Thomas Kahan
16:10
Modulating Cardiovascular Risk with Antidiabetic therapy: The Big Surprise an...
11:01
The Paradox of Smoking and Obesity During the Prevention of Atherosclerosis -...
14:47
Clinical Data with PCSK9 inhibitors - Alberto Lorenzatti
14:49
Lipid Lowering with Statins and Ezetimibe: The Role in 2017 - Álvaro Sosa Lip...
Video Player is loading.
This is a modal window.
The media could not be loaded, either because the server or network failed or because the format is not supported.
New Trends in Atherosclerosis – Advances in Lipid Management - Prof. Julian Halcox
25 views
Summary
Julian Halcox discusses the new trends in atherosclerosis and advances in lipid management
- Role of patient in self-care cardiovascular risk reduction
- Importance of lifestyle...
Summary
Julian Halcox discusses the new trends in atherosclerosis and advances in lipid management
- Role of patient in self-care cardiovascular risk reduction
- Importance of lifestyle changes
- Risk factor control and blood pressure reduction (Sprint study)
- Role of lipid current lowering agents (e.g. Statins)
- Newer lipid lowering agents on the horizon (e.g. PCSK9 inhibitors)
Simple Education
1,191 videos
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.
Speakers
A consultant cardiologist at Swansea University College of Medicine, UK. Features in 4 videos on... A consultant cardiologist at Swansea University College of Medicine, UK. Features in 4 videos on Wondr Medical. Julian Halcox generally speaks on PCSK9 Antagonists, Statins, Cardiology, and Hypertension.
Join the conversation
to comment
